Tongue graft-versus-host disease: remission with ruxolitinib

Katerina Grafanaki; Spyridon Lygeros; Alexandros Spyridonidis; Maria Liga

doi:10.1136/bcr-2021-247888

Article info

Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)

Tongue graft-versus-host disease: remission with ruxolitinib

Authors

Katerina Grafanaki Department of Dermatology, University Hospital of Patras, School of Medicine, Patras, Rion, Greece PubMed articles Google scholar articles
Spyridon Lygeros Ear, Nose, Throat Department, University General Hospital of Patras, Patras, Rion, Greece PubMed articles Google scholar articles
Alexandros Spyridonidis Bone Marrow Transplantation Unit, Department of Internal Medicine, University Hospital of Patras, Rion, Greece PubMed articles Google scholar articles
Maria Liga Bone Marrow Transplantation Unit, Department of Internal Medicine, University Hospital of Patras, Rion, Greece PubMed articles Google scholar articles

Correspondence to Dr Katerina Grafanaki; grafanaki{at}med.upatras.gr

View Full Text

Citation

Grafanaki K, Lygeros S, Spyridonidis A, et al

Tongue graft-versus-host disease: remission with ruxolitinib

BMJ Case Reports CP 2022;15:e247888.

Publication history

Accepted May 6, 2022
First published May 23, 2022.

Online issue publication

May 23, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password